Skip to main content
Andres Matoso, MD, Pathology, Baltimore, MD

AndresMatosoMD

Pathology Baltimore, MD

Gastrointestinal & Hepatobiliary Pathology, Genitourinary Pathology, Anatomic Pathology, Clinical Pathology

GU Pathology Fellow

Dr. Matoso is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Matoso's full profile

Already have an account?

  • Office

    1800 Orleans Street
    Baltimore, MD 21287
    Phone+1 410-955-5000
    Fax+1 410-955-5001

Summary

  • I am an AP/CP board certified pathologist with sub specialty expertise in GI and GU pathology.

Education & Training

  • Department of Pathology and Laboratory Medicine Johns Hopkins Hospital
    Department of Pathology and Laboratory Medicine Johns Hopkins HospitalFellowship, Urologic Pathology, 2013
  • Rhode Island Medical Center
    Rhode Island Medical CenterFellowship, Gastrointestinal Pathology, 2012 - 2013
  • Rhode Island Hospital/Brown University
    Rhode Island Hospital/Brown University2008 - 2012
  • Weill Cornell Medicine
    Weill Cornell MedicinePost-Doctoral Fellowship, 2006 - 2008
  • University  of Buenos Aires
    University of Buenos Aires2002 - 2005
  • University of Buenos Aires
    University of Buenos AiresClass of 2001

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2024 - 2026
  • MD State Medical License
    MD State Medical License 2012 - 2025
  • DC State Medical License
    DC State Medical License 2016 - 2024
  • RI State Medical License
    RI State Medical License 2007 - 2018
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of PathologyAP/CP

Awards, Honors, & Recognition

  • Stowell-Orbison Award United States & Canadian Academy of Pathology, 2013
  • New Investigator Award Winner Rhode Island Hospital/Brown University, 2012
  • New Investigator Award Finalist Rhode Island Hospital/Brown University, 2010
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Association of Impaired Spermatogenesis with the Use of Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma  
    Jody E Hooper, Andres Matoso, JAMA Oncology
  • Expression Microarray Analysis Identifies of Novel Protein Markers in Eosinophilic Esophagitis.  
    Matoso A, Mukkada VA, Lu S, Monahan R, Cleveland K, Noble L, Mangray S, Resnick MB, Mod Pathol
  • Sympathetic ophtalmia following enucleation.  
    Tseng VL, Matoso A, Hofmann RJ, Graefes Arch Clin Exp Ophthalmol

Books/Book Chapters

Abstracts/Posters

  • Molecular Mechanismsof Met Regulation by p53 in Ovarian Cancer.
    Matoso A, Hwang C-I, Flesken-Nikitin A, Ellenson LH, Nikitin AY, Center for Vertebrate Genomics, Annual Symposium
  • Mutually Exclusive Mutations between Men1 and Rb in Neuroendocrine Neoplasia.
    Matoso A, Zhou Z, Hayama R, Flesken-Nikitin A, Nikitin AY, Cornell University
  • ALDH1 Expression in Bladder Cancer Correlates with Histopathologic Indicators of Poor Prognosis.
    Elsamra SE, Matoso A, Singh K, Tavares R, Noble L, Renzulli J, Haleblian G, Resnick MB, Wang LJ, Pareek G, New England Section of the American Urological Association
  • Join now to see all

Lectures

  • Differentially expressed proteins in eosinophilic esophagitis: identification of easily detectable markers with potential diagnostic utility. 
    20th Annual Hospital Research Celebration
  • Expression of stem cell marker ALDH1 correlates with muscle invasion in transitional cell carcinoma of the bladder. 
    18th Annual Hospital Research Celebration
  • Prostatic Lesions of Ductal Morphology. 
    Pathology Grand Rounds, Rhode Island Hospital
  • Join now to see all

Authored Content

  • Association of Impaired Spermatogenesis with the Use of Immune Checkpoint Inhibitors in Patients with Metastatic MelanomaJune 2020

Other Languages

  • Spanish